Home/Bioinorganic Chemistry and Applications/Article Record
Peer-Reviewed Article July 24, 2018

Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Bioinorganic Chemistry and Applications
Publisher: Hindawi Publishing Corporation • Egypt • 1565-3633
DOI: https://doi.org/10.1155/2018/3924608

Abstract

Cytochromes P450 are a class of metalloproteins which are responsible for electron transfer in a wide spectrum of reactions including metabolic biotransformation of endogenous and exogenous substrates. The superfamily of cytochromes P450 consists of families and subfamilies which are characterized by a specific structure and substrate specificity. Cytochromes P450 family 1 (CYP1s) play a distinctive role in the metabolism of drugs and chemical procarcinogens. In recent decades, these hemoproteins have been intensively studied with the use of computational methods which have been recently developed remarkably to be used in the process of drug design by the virtual screening of compounds in order to find agents with desired properties. Moreover, the molecular modeling of proteins and ligand docking to their active sites provide an insight into the mechanism of enzyme action and enable us to predict the sites of drug metabolism. The review presents the current status of knowledge about the use of the computational approach in studies of ligand-enzyme interactions for CYP1s. Research on the metabolism of substrates and inhibitors of CYP1s and on the selectivity of their action is particularly valuable from the viewpoint of cancer chemoprevention, chemotherapy, and drug-drug interactions.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

60
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.